摘要
胆汁淤积(cholestasis)因胆汁摄取、合成或分泌障碍引起,也可因胆道梗阻形成。引起胆汁淤积的病因多样,肝细胞、胆管细胞以及肠道的胆汁酸转运体密切参与胆汁淤积的发病.近年来的研究以此为靶点取得诸多进展.并为胆汁淤积的诊断和治疗提供了新的思路和方法。
出处
《内科理论与实践》
2014年第5期301-304,共4页
Journal of Internal Medicine Concepts & Practice
参考文献28
-
1European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267.
-
2Beuers U, Bilzer M, Cbittattu A, et al. Tauroursodeoxy- cholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mecha- nisms in cholestatic rat liver[J]. Hepatology, 2001, 33(5): 1206-1216.
-
3Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver dis- ease[J]. Gastroenterology, 2004, 126(1): 322-342.
-
4Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation[J]. Physiol Rev, 2003, 83(2): 633-671.
-
5Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P- glycoprotein represents the eanalicular bile salt export pump of mammalian liver[J]. J Biol Chem, 1998, 273(16): 10046-10050.
-
6Lo Sasso G, Petruzzelli M, Moschetta A. A translational view on the biliary lipid secretory network[J]. Biochim Biophys Acta, 2008, 1781(13): 79-96.
-
7Cascorbi 1. P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations [J]. Handb Exp Pharmacol, 2011, 201: 261-283.
-
8Wagner M, Zollner G, Trauner M. Nuclear receptor regu- lation of the adaptive response of bile acid transporters in cholestasis[J]. Semin Liver Dis, 2010, 30(2): 160-177.
-
9Keitel V, Burdelski M, Warskulat U, et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis[J]. Hepatolo- gy, 2005, 41(5): 1160-1172.
-
10Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids[J]. Science, 1999, 284 (5415): 1362-1365.
二级参考文献14
-
1沈镭,陆伦根.腺苷蛋氨酸在胆汁淤积性肝病治疗中的应用[J].胃肠病学,2006,11(3):190-191. 被引量:27
-
2陆伦根,曾民德.胆汁酸盐转运体:分子特征、功能和调节//陆伦根,曾民德.胆汁淤积性肝病.北京:人民卫生出版社,2007:42-74.
-
3Paumgartner G, Pusl T. Medical treatment of cholestatic liver disease. Clin Liver Dis, 2008, 12: 53-80, viii.
-
4Tietz PS, LaRusso NF. Cholangiocyte biology. Curr Opin Gastroenterol, 2005, 21 : 337-343.
-
5Masyuk AI, Masyuk TV, Splinter PL, et al. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology, 2006, 131:911- 920.
-
6Stedman C, Liddle C, Coulter S, et al. Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci U S A, 2006, 103: 11323-11328.
-
7Zollner G, Marschall HU, Wagner M, et al. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm, 2006, 3:231-251.
-
8Sola S, Amaral JD, Aranha MM, et al. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. Curr Med Chem, 2006, 13: 3039-3051.
-
9Sola S, Aranha MM, Steer C J, et al. Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid. Curr Issues Mol Biol, 2007, 9: 123-138.
-
10Lefkowitch JH. Histological assessment of cholestasis. Clin Liver Dis, 2004, 8: 27-40, v.
共引文献4
-
1王计,程鹏.腺苷蛋氨酸联合熊去氧胆酸治疗肝内胆汁淤积症30例临床观察[J].咸宁学院学报(医学版),2012,26(4):309-311. 被引量:6
-
2郜英,宋茂舟,梁超蓉.腺苷蛋氨酸联合熊去氧胆酸治疗慢性乙型重度淤胆型肝炎临床观察[J].山西中医学院学报,2013,14(3):68-69. 被引量:5
-
3陆伦根.胆汁淤积性肝病的正确认识与科学管理[J].实用肝脏病杂志,2019,22(5):754-757. 被引量:8
-
4杨永生,亢泽峰,陆烨凯,陈倩倩,韩冉,卢伟,张鸣凤,马智勇,黄桂芹,徐会选.N-乙酰半胱氨酸联合熊去氧胆酸治疗慢性肝内胆汁淤积性肝病效果分析[J].肝脏,2019,24(12):1479-1480. 被引量:5
同被引文献59
-
1崔金玲,任新生.脓毒症发生早期肝功能障碍的临床研究[J].岭南急诊医学杂志,2007,12(4):251-252. 被引量:12
-
2胡清华,杨兰,杨翠红.细胞因子和肝功能监测与脓毒血症预后的关系[J].武汉大学学报(医学版),2006,27(5):657-659. 被引量:2
-
3李秀红,关莉莉.测定血清总胆汁酸(TBA)在诊断妊娠期肝内胆汁淤积症(ICP)的临床意义[J].中外健康文摘,2012,9(52):187-188.
-
4Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[ J]. N Engl J Med, 2003, 348 (16) : 1546 - 1554.
-
5Blaneo J, Muriel - Bombin A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study[J]. Crit Care, 2008, 12(6) :R158.
-
6Nesseler N, Launey Y, Aninat C, et al. Clinical review: the liver in sepsis[J]. Crit Care, 2012, 16(5) :235.
-
7Ring A, Stremmel W. The hepatic microvaseular responses to sep- sis[ J ]. Semin Thromb Hemost, 2000, 26 (5) :589 - 594.
-
8Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure[J]. Anat Rec, 2008, 291(6) :714 -720.
-
9Koo D J, Chaudry IH, Wang P. Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis[J]. J Surg Res, 1999, 83(2) :151 -157.
-
10Li XH, Wu M J, Zhang LN, et al. Effects of polydatin on ALT, AST,TNF- alpha, and COX- 2 in sepsis model mice[ J]. Zhong- guo Zhong Xi Yi Jie He Za Zhi,2013,33(2) : 225 -228.
引证文献3
-
1韦桂云.血清腺苷脱氨酶检测在妊娠期肝内胆汁淤积症中的应用价值[J].广西医学,2015,37(12):1776-1778.
-
2王晓琴,李培杰.脓毒症肝功能障碍发病机制的研究进展[J].中国急救医学,2016,36(3):224-228. 被引量:8
-
3蔡婷婷,梁永明,薛秋平,陈勇.连续性肾脏替代治疗改善脓毒症患者早期肝功能障碍的临床探讨[J].中国血液净化,2018,17(2):78-81. 被引量:8
二级引证文献16
-
1高林.早期连续性肾脏替代治疗对严重脓毒症患者炎症介质及免疫功能的影响[J].医疗装备,2020,0(3):73-74. 被引量:3
-
2蔡婷婷,梁永明,薛秋平,陈勇.连续性肾脏替代治疗改善脓毒症患者早期肝功能障碍的临床探讨[J].中国血液净化,2018,17(2):78-81. 被引量:8
-
3杨广,李健,常卫东.活血法治疗脓毒症肠功能障碍的理论探讨[J].中国中西医结合消化杂志,2017,25(12):986-989. 被引量:13
-
4何俊俐,沈贵月,刘安定,江晓静.FK866对脓毒症小鼠肝损伤的保护作用[J].中华危重病急救医学,2018,30(6):583-587. 被引量:5
-
5周杰,刘文明,许峂嵘,蒋建红,杨巧云.脓毒症相关胆汁淤积性肝功能障碍的回顾性研究[J].中国中西医结合急救杂志,2018,25(4):346-350. 被引量:6
-
6邢小康,李曼,郭丰.脓毒症相关肝损伤分析[J].中国继续医学教育,2018,10(27):87-88. 被引量:8
-
7赵广明,胡占升.脓毒症肝损伤的发病机制与治疗研究进展[J].解放军医学杂志,2019,44(6):515-520. 被引量:21
-
8杜粉静,许娟,王娟.连续肾脏替代疗法治疗不明原因发热合并多脏器功能障碍的近期临床价值[J].临床误诊误治,2019,32(9):44-48. 被引量:5
-
9李娜娜,张馨予,杨威,孟祥林,赵鸣雁,于凯江,刘微,康凯.PPAR-β在脓毒症肝损伤中的保护作用[J].中国普外基础与临床杂志,2019,26(12):1495-1499. 被引量:1
-
10肖俐.早期连续性肾脏替代治疗在危重型蝰蛇伤救治中的应用及护理[J].按摩与康复医学,2020,11(8):88-89.
-
1杨程德.细胞核及其相关成份自身抗体的临床研究现状[J].临床检验杂志,1998,16(3):180-182.
-
2张学武,席思川.拉米夫定治疗乙型病毒性肝炎临床研究现状[J].中国实用内科杂志,2000,20(10):631-633. 被引量:21
-
3潘革.新生儿甲状腺功能变化及其临床研究现状[J].医学文选,2000,19(1):94-95.
-
4王辰,翟振国.肺血栓栓塞症-深静脉血栓形成的预防策略[J].实用心脑肺血管病杂志,2006,14(1):1-3. 被引量:13
-
5马欣,诸荣恩.转铁蛋白临床研究现状[J].中国实用内科杂志,1995,15(9):556-558. 被引量:1
-
6刘敬东.医院内获得性肺炎MRSA感染临床研究现状[J].浙江临床医学,2001,3(3). 被引量:8
-
7恽佶例,李玉明.粒细胞集落刺激因子治疗心肌梗死后心室重塑的研究进展[J].心血管病学进展,2008,29(3):441-444. 被引量:2
-
8韩玉坤,陈菊梅.自身免疫性肝炎临床研究现状[J].中华肝脏病杂志,2004,12(3):180-181. 被引量:13
-
9黄宗干.骨髓增生异常综合征临床研究现状(Ⅱ)[J].四川医学,1993,14(6):363-364.
-
10张孝忠,彭整军.Brugada综合征的研究现状[J].解放军保健医学杂志,2003,5(1):60-61.